765 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by Atlanta Consulting Group Advisors LLC

Atlanta Consulting Group Advisors LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 765 shares of the company’s stock, valued at approximately $311,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Natixis Advisors LLC raised its position in HCA Healthcare by 2.3% during the third quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock valued at $44,750,000 after purchasing an additional 2,459 shares in the last quarter. Mizuho Securities USA LLC lifted its position in shares of HCA Healthcare by 205.4% during the 3rd quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company’s stock worth $18,548,000 after buying an additional 30,693 shares during the last quarter. Simplify Asset Management Inc. raised its stake in HCA Healthcare by 67.1% during the third quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company’s stock worth $956,000 after acquiring an additional 944 shares in the last quarter. Valley Wealth Managers Inc. boosted its stake in shares of HCA Healthcare by 14.4% in the 3rd quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company’s stock valued at $562,000 after purchasing an additional 174 shares in the last quarter. Finally, Empowered Funds LLC lifted its stake in HCA Healthcare by 10.2% in the 3rd quarter. Empowered Funds LLC now owns 21,824 shares of the company’s stock valued at $8,870,000 after purchasing an additional 2,019 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last quarter. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 0.7 %

HCA stock opened at $342.96 on Monday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $238.82 and a fifty-two week high of $417.14. The stock’s 50 day simple moving average is $385.11 and its 200 day simple moving average is $357.92. The company has a market cap of $86.87 billion, a P/E ratio of 15.40, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on HCA shares. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Leerink Partners lifted their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, UBS Group lifted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.